Skip to main content

Table 1 Percent of patients gaining or losing 3 lines of vision

From: Long term results of patients with neovascular age-related macular degeneration switched from other anti-VEGF agents to intravitreal Aflibercept

 

At switch

3 months

3 years

4 years

3 lines gained

25.0%

29.5%

27.3%

32.1%

3 lines lost

2.3%

2.3%

10.2%

10.7%

  1. Over 4 years after switching from other anti-VEGF agents to aflibercept, the number of 3-line gainers increased from 25.0 to 32.1% by 4 years, while the number of 3-line losers increased from 2.3 to 10.7% by 4 years
Back to article page

International Journal of Retina and Vitreous

ISSN: 2056-9920

Contact us